Effects of carnitine on thyroid hormone action

Area of Science:

• Endocrinology
• Cell Biology
• Nutritional Science

Background:

• Thyroid hormones, thyroxine (T4) and triiodothyronine (T3), regulate cellular metabolism primarily through nuclear receptors.
• Hyperthyroidism, a condition of excess thyroid hormone, leads to various clinical symptoms and biochemical alterations.
• Tissue carnitine levels can be depleted in hyperthyroid states.

Purpose of the Study:

• To validate L-carnitine as a peripheral antagonist of thyroid hormone action.
• To investigate the effect of L-carnitine on thyroid hormone entry into cell nuclei.
• To assess the efficacy of L-carnitine in managing hyperthyroid symptoms and biochemical changes.

Main Methods:

• In vitro experiments on target cells (neurons, hepatocytes, fibroblasts) exposed to thyroid hormones.
• A randomized clinical trial involving patients with iatrogenic hyperthyroidism.
• Administration of oral L-carnitine at doses of 2 and 4 grams per day.

Main Results:

• L-carnitine was shown to inhibit the cellular nuclear entry of both T3 and T4.
• Oral L-carnitine (2-4g/day) reversed existing hyperthyroid symptoms and biochemical markers.
• L-carnitine also prevented or minimized the development of hyperthyroid symptoms and biochemical changes.
• While some parameters were unaffected, osteocalcin showed beneficial bone effects despite hyperthyroid changes.
• Recent observations suggest L-carnitine's utility in severe hyperthyroidism, including thyroid storm.

Conclusions:

• L-carnitine functions as a peripheral antagonist to thyroid hormone action by blocking nuclear entry.
• L-carnitine demonstrates significant therapeutic potential in managing hyperthyroidism, including symptom reversal and prevention.
• The findings support the use of L-carnitine in specific clinical scenarios of hyperthyroidism, particularly given carnitine depletion in the condition.